Viewing StudyNCT00126490



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126490
Status: COMPLETED
Last Update Posted: 2015-06-30
First Post: 2005-08-02

Brief Title: Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-03
Start Date Type: None
Primary Completion Date: 2012-06
Primary Completion Date Type: ACTUAL
Completion Date: 2013-08
Completion Date Type: ACTUAL
First Submit Date: 2005-08-02
First Submit QC Date: August 2 2005
Study First Post Date: 2005-08-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-07-30
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-06-03
Last Update Post Date: 2015-06-30
Last Update Post Date Type: ESTIMATED